You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage III Non-Small Cell Lung Cancer (NSCLC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Changsha (Sugemalimab and Chemotherapy)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Sugemalimab and Chemotherapy
  • Changsha, China
    Hunan Cancer Hospital
Jul 7, 2023

Non-small-cell Lung Cancer Patients Trial in Roma (Durvalumab, Olaparib tablet, Single-agent chemo)

Recruiting
  • Non-small-cell Lung Cancer Patients
  • Roma, RM, Italy
    Istituti Fisioterapici Ospitalieri- Ifo - Istituto Regina Elena
Sep 30, 2022

Reveal Patterns of Presentation, Management and Outcome of SCLC

Recruiting
  • Lung Cancer
    • Dammam, Saudi Arabia
    • +2 more
    Jul 25, 2022

    NSCLC, NSCLC Trial in Switzerland (Durvalumab, Radiotherapy)

    Recruiting
    • Non-small Cell Lung Cancer
    • NSCLC
    • Aarau, Switzerland
    • +12 more
    Oct 17, 2022

    NSCLC, Stage III Trial in Chengdu (GFH018, Toripalimab, Paclitaxel)

    Not yet recruiting
    • NSCLC, Stage III
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    May 23, 2022

    NSCLC Trial in Beijing

    Recruiting
    • NSCLC
      • Beijing, China
        Yuyan Wang
      Oct 10, 2023

      Omitting Clinical Target Volume in Radical Treatment of

      Not yet recruiting
      • Immunotherapy
      • +3 more
      • IMRT+adjuvant immunotherapy
      • (no location specified)
      Jun 9, 2023

      Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

      Not yet recruiting
      • Lung Cancer, Nonsmall Cell
      • Lung Cancer Stage III
      • Nivolumab and Chemotherapy
      • +3 more
      • (no location specified)
      Aug 15, 2023

      Nonsmall Cell Lung Cancer, Nonsmall Cell Lung Cancer, Stage II, Nonsmall Cell Lung Cancer Stage III Trial in Tampa (Genomically

      Recruiting
      • Nonsmall Cell Lung Cancer
      • +3 more
      • Genomically Guided Radiation Therapy (RT)
      • Tampa, Florida
        Moffitt Cancer Center
      May 23, 2023

      Lung Cancer Stage III Trial (ctDNA)

      Not yet recruiting
      • Lung Cancer Stage III
      • ctDNA
      • (no location specified)
      Oct 26, 2023

      NSCLC Trial in Worldwide (Alectinib, Entrectinib, Pralsetinib)

      Recruiting
      • Non-Small Cell Lung Cancer
      • San José, Costa Rica
      • +3 more
      Aug 4, 2022

      Non Small Cell Lung Cancer Trial in Salt Lake City (radiation, device, drug)

      Not yet recruiting
      • Non Small Cell Lung Cancer
      • carboplatin chemotherapy
      • +2 more
      • Salt Lake City, Utah
        Huntsman Cancer Institute
      Nov 3, 2023

      NSCLC Trial in Shanghai (SH-1028 tablets, Placebo SH-1028 tablets)

      Recruiting
      • Non-small Cell Lung Cancer
      • SH-1028 tablets
      • Placebo SH-1028 tablets
      • Shanghai, Shanghai, China
        Shanghai Pulmonary Hospital
      Oct 6, 2023

      Stage III NSCLC, Surgery Trial in Guangzhou (Lorlatinib)

      Not yet recruiting
      • Stage III NSCLC
      • Surgery
      • Guangzhou, Guangdong, China
        Guangdong Provincial People's Hospital
      Feb 21, 2023

      Acute Side Effects In Stage III NSCLC With Definitive CRT

      Completed
      • Non-small Cell Lung Cancer Stage III
        • Ankara, Turkey
          Ankara University Medicine School Radiation Oncology
        Aug 22, 2023

        NSCLC Stage III Trial (radiotherapy, Platinum-Based Drug, Immunotherapy)

        Not yet recruiting
        • Non-small Cell Lung Cancer Stage III
        • radiotherapy
        • +3 more
        • (no location specified)
        Sep 10, 2023

        Stage III NSCLC Trial in Chengdu (Durvalumab, nanoparticle albumin bound paclitaxel, low dose radiation therapy)

        Recruiting
        • Stage III Non-small Cell Lung Cancer
        • Chengdu, Sichuan, China
          Sichuan Cancer Hospital
        Dec 2, 2021

        Standard of Care Lifestyle Support for Stage III NSCLC Patients

        Not yet recruiting
        • Non Small Cell Lung Cancer
        • Lifestyle advice
        • (no location specified)
        Aug 23, 2022

        Non Small Cell Lung Cancer, Pancreatic Cancer, Colorectal Cancer Trial in United States (BMF-219)

        Recruiting
        • Non Small Cell Lung Cancer
        • +16 more
        • Goodyear, Arizona
        • +10 more
        Jan 24, 2023

        NSCLC Trial in Tianjing (Envalfolimab subcutaneously injected+Platinum-based doublet chemo intravenous injection,

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • Envalfolimab subcutaneously injected+Platinum-based doublet chemotherapy intravenous injection
        • placebo subcutaneously injected +Platinum-based doublet chemotherapy intravenous injection
        • Tianjing, Tianjin, China
          Tianjin cancer hospital
        Nov 3, 2023

        Stage III NSCLC, Locally Advanced, Unresectable Trial (standard Radiotherapy, Chemotherapy, Immunotherapy)

        Not yet recruiting
        • Stage III Non-small Cell Lung Cancer
        • +2 more
        • standard Radiotherapy
        • +3 more
        • (no location specified)
        Oct 20, 2023

        Non Small Cell Lung Cancer, Lung Cancer Stage III Trial in Dallas (Thoracic RT and Durvalumab, Consolidative Durvalumab)

        Active, not recruiting
        • Non Small Cell Lung Cancer
        • Lung Cancer Stage III
        • Thoracic RT and Durvalumab
        • Consolidative Durvalumab
        • Dallas, Texas
          Simmons Comprehensive Cancer Center at University of Texas South
        Sep 27, 2021

        NSCLC, Non-small Cell Carcinoma, NSCLC Stage I Trial (Stereotactic body radiotherapy, Hypofractionated radiotherapy, Durvalumab)

        Not yet recruiting
        • Non-small Cell Lung Cancer
        • +4 more
        • Stereotactic body radiotherapy
        • +2 more
        • (no location specified)
        Jul 5, 2022

        NSCLC Trial in Tampa, Chapel Hill, Durham (Thoracic Radiotherapy, Platinum Based Chemotherapy, Ipilimumab)

        Active, not recruiting
        • Carcinoma, Non-Small-Cell Lung
        • Thoracic Radiotherapy
        • +3 more
        • Tampa, Florida
        • +2 more
        Sep 30, 2022

        Metastatic Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Non-Small Cell Cancer AJCC v7

        Active, not recruiting
        • Metastatic Lung Non-Small Cell Carcinoma
        • +5 more
        • Laboratory Biomarker Analysis
        • +3 more
        • New Haven, Connecticut
        • +4 more
        Jan 27, 2023